Title : Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.

Pub. Date : 2021 Sep

PMID : 34322995






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Furthermore, inhibition of JAK1/2 by baricitinib and ruxolitinib synergizes docetaxel sensitivity in both androgen receptor (AR)-negative DU145 and PC3 cells, but not in the AR-positive LNCaP cells. Docetaxel androgen receptor Homo sapiens
2 Furthermore, inhibition of JAK1/2 by baricitinib and ruxolitinib synergizes docetaxel sensitivity in both androgen receptor (AR)-negative DU145 and PC3 cells, but not in the AR-positive LNCaP cells. Docetaxel androgen receptor Homo sapiens